Back
Allogene Therapeutics Stock Price Chart
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
15
ALLO
Allogene Therapeutics
Last Price:
2.27
Seasonality Move:
6.59%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLO is experiencing selling pressure, which indicates risk of future bearish movement.
Allogene Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.86 | Sell |
| 20-day SMA: | 2.78 | Sell |
| 50-day SMA: | 2.75 | Sell |
| 200-day SMA: | 3.17 | Sell |
| 8-day EMA: | 2.69 | Sell |
| 20-day EMA: | 2.76 | Sell |
| 50-day EMA: | 2.74 | Sell |
| 200-day EMA: | 3.07 | Sell |
Allogene Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 36.04 | Sell |
| Chaikin Money Flow: | -2840160 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.54 - 3) | Sell |
| Bollinger Bands (100): | (2.41 - 2.95) | Sell |
Allogene Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Allogene Therapeutics Stock
Is Allogene Therapeutics Stock a Buy?
- Allogene Therapeutics share price is 2.27 while ALLO 8-day simple moving average is 2.86, which is a Sell signal.
- The stock price of ALLO is 2.27 while Allogene Therapeutics 20-day SMA is 2.78, which makes it a Sell.
- Allogene Therapeutics 50-day simple moving average is 2.75 while ALLO share price is 2.27, making it a Sell technically.
- ALLO stock price is 2.27 and Allogene Therapeutics 200-day simple moving average is 3.17, creating a Sell signal.
ALLO Technical Analysis vs Fundamental Analysis
Sell
15
Allogene Therapeutics (ALLO)
is a Sell
Is Allogene Therapeutics a Buy or a Sell?
-
Allogene Therapeutics stock is rated a Sell
The current Allogene Therapeutics [ALLO] share price is $2.27. The Score for ALLO is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
Allogene Therapeutics Stock Info
Market Cap:
475.96M
Price in USD:
2.27
Share Volume:
3.08M
Allogene Therapeutics 52-Week Range
52-Week High:
5.78
52-Week Low:
2.01
Sell
15
Allogene Therapeutics (ALLO)
is a Sell
Allogene Therapeutics Share Price Forecast
-
What is the Allogene Therapeutics stock price today?
The Allogene Therapeutics stock price is 2.27 USD today. -
Will ALLO stock go up or go down?
Allogene Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Allogene Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Allogene Therapeutics is overvalued.
Is Allogene Therapeutics Stock a Buy?
- Allogene Therapeutics share price is 2.27 while ALLO 8-day exponential moving average is 2.69, which is a Sell signal.
- The stock price of ALLO is 2.27 while Allogene Therapeutics 20-day EMA is 2.76, which makes it a Sell.
- Allogene Therapeutics 50-day exponential moving average is 2.74 while ALLO share price is 2.27, making it a Sell technically.
- ALLO stock price is 2.27 and Allogene Therapeutics 200-day simple moving average is 3.07, creating a Sell signal.
Fundamental Analysis of Allogene Therapeutics
Is Allogene Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.06 per share.
Technical Analysis of Allogene Therapeutics
Should I short Allogene Therapeutics stock?
- ALLO Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Allogene Therapeutics is a Sell
- Allogene Therapeutics Relative Strength Index (RSI) is 36.04, which suggest Allogene Therapeutics is oversold
- The Bollinger Bands (25) for Allogene Therapeutics is (2.54 - 3), which suggest Allogene Therapeutics is a Sell
- The Bollinger Bands (100) for Allogene Therapeutics is (2.41 - 2.95), which suggest Allogene Therapeutics is a Sell
* Allogene Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.